i
SUPPLEMENTARY TABLE 1. Search strategy to identify recombinant zoster vaccine (RZV) reports of selected pre-specified outcomes in the Vaccine Adverse Events Reporting System (VAERS) — United States, October 2017–June 2018
-
February 28, 2019
Source: MMWR. Morbidity and Mortality Weekly Report ; v. 68, no. 4
Details:
-
Description:Supplements: Post-licensure safety Surveillance of recombinant zoster vaccine (Shingrix) —Vaccine Adverse Event Reporting System (VAERS), United States, October 2017–June 2018
-
Subject:
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +